Action myoclonus — renal failure syndrome : characterization of a unique cerebro-renal disorder

Correspondence to: Eva Andermann, MD, PhD, FCCMG, Neurogenetics Unit, Room 127, Montreal Neurological Hospital and Institute, 3801 University Street, Montreal, Quebec H3A 2B4, Canada E-mail: eva.andermann@mcgill.ca Neurogenetics Unit and Epilepsy Service, Montreal Neurological Hospital and Institute, Department of Human Genetics, Department of Neurology and Neurosurgery, Department of Pediatrics and MRS Unit, McConnell Brain Imaging Center, McGill University, Département de Génetique Médicale, Hôpital Sainte-Justine, Montreal, Service de Neurologie, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, British Columbia Neuropsychiatry Program, Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada, Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Department of Pathology, Alfred Hospital, Department of Anatomical Pathology, Royal Melbourne Hospital, Department of Neurology, Royal Melbourne Hospital, Melbourne Victoria, Australia and Parkinson’s Disease and Other Movement Disorders Center, Mayo Clinic, Scottsdale, Arizona, USA, Universität Göttingen, Paracelsus-Elena-Klinik, Kassel, Max Planck Institut für Psychiatrie and Institute of Human Genetics, National Research Center, Munich, Germany, Instituto de Neurologia Pilar, Hospital N. S. Pilar, Curitiba, Brazil and Serviço de Anatomia Patológica, Hospital de São João, Porto, Portugal

[1]  M. Barmada,et al.  African American hypertensive nephropathy maps to a new locus on chromosome 9q31-q32. , 2003, American journal of human genetics.

[2]  M. Barmada,et al.  Autosomal dominant progressive nephropathy with deafness: linkage to a new locus on chromosome 11q24. , 2003, Journal of the American Society of Nephrology : JASN.

[3]  H. Tanabe,et al.  Positional Candidate Approach for the Gene Responsible for Benign Adult Familial Myoclonic Epilepsy , 2002, Epilepsia.

[4]  F. Dubeau,et al.  Long-term efficacy and safety of piracetam in the treatment of progressive myoclonus epilepsy. , 2001, Archives of neurology.

[5]  J. Kaplan,et al.  Familial focal segmental glomerulosclerosis , 2001, Current opinion in nephrology and hypertension.

[6]  O. Mehls,et al.  Familial steroid-resistant nephrotic syndromes: recent advances. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  H. Tsukaguchi,et al.  A locus for adolescent and adult onset familial focal segmental glomerulosclerosis on chromosome 1q25-31. , 2000, Journal of the American Society of Nephrology : JASN.

[8]  Corinne Antignac,et al.  NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome , 2000, Nature Genetics.

[9]  H. Rennke,et al.  Collapsing glomerulopathy in HIV and non-HIV patients: a clinicopathological and follow-up study. , 1999, Kidney international.

[10]  M. Pericak-Vance,et al.  Spectrum of disease in familial focal and segmental glomerulosclerosis. , 1999, Kidney international.

[11]  M. Pericak-Vance,et al.  Linkage of a gene causing familial focal segmental glomerulosclerosis to chromosome 11 and further evidence of genetic heterogeneity. , 1999, Genomics.

[12]  L. Grcevska,et al.  Collapsing glomerulopathy: clinical characteristics and follow-up. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  A. Meyrier Collapsing glomerulopathy: expanding interest in a shrinking tuft. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  L Peltonen,et al.  Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome. , 1998, Molecular cell.

[15]  R. Falk,et al.  Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis. , 1994, Kidney international.

[16]  F. Andermann,et al.  Progressive Myoclonus Epilepsies: Clinical and Genetic Aspects , 1993 .

[17]  Andermann Classification of progressive myoclonus epilepsies and related disorders , 1990, Annals of neurology.

[18]  A. Lockwood Neurologic complications of renal disease. , 1989, Neurologic clinics.

[19]  F. Andermann,et al.  Kufs' disease: a critical reappraisal. , 1988, Brain : a journal of neurology.

[20]  F. Andermann,et al.  Progressive myoclonus epilepsies: specific causes and diagnosis. , 1986, The New England journal of medicine.

[21]  A. Arieff,et al.  Uremic encephalopathies: clinical, biochemical, and experimental features. , 1982, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  R. Ross,et al.  Pigment Variant of Neuronal Ceroid-Lipofuscinosis (Kufs’ Disease) , 1977, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[23]  F. Andermann,et al.  Genetic and Family Studies in Friedreich's Ataxia , 1976, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[24]  E. Zerbin-Rüdin [Genetics in medicine]. , 1969, Wiener medizinische Wochenschrift.

[25]  P. R. David,et al.  Principles of Human Genetics , 1960, Diabetes.

[26]  R. Ahonen Peripheral neuropathy in uremic patients and in renal transplant recipients , 2004, Acta Neuropathologica.

[27]  M. Soto,et al.  Familial collapsing glomerulopathy: clinical, pathological and immunogenetic features. , 2003, Kidney international.

[28]  J. Kaplan,et al.  Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. , 2000, Nature genetics.

[29]  F. Andermann,et al.  Action myoclonus-renal failure syndrome: a previously unrecognized neurological disorder unmasked by advances in nephrology. , 1986, Advances in neurology.

[30]  F. Andermann,et al.  The ultrastructural characteristics of the abnormal cytosomes in Batten-Kufs' disease. , 1977, Brain : a journal of neurology.